InvestorsHub Logo
Followers 8
Posts 333
Boards Moderated 0
Alias Born 09/09/2009

Re: None

Friday, 03/30/2012 10:16:23 AM

Friday, March 30, 2012 10:16:23 AM

Post# of 650108
ALXA .60 potential explosive runner in the near term. Just based on the chart alone, it is ready for a pop.

http://stockcharts.com/h-sc/ui?s=ALXA


It has two major catalysts.
1. It has a FDA decision date of May 4th for it's inhaled antipsychotic drug Adasuve (Staccato Loxipine). Loxapine is already available in the US, this would be an inhaled version.

http://finance.yahoo.com/news/Alexza-Announces-Extension-prnews-391788033.html?x=0

2. They have a partner Grupo Ferrer that will distribute the drug in Europe, Latin America, and Russia and instead of milestone payments to Alexa, they have agreed to purchase 2.42 million common shares of ALXA at a price of 1.24, 100% gain from current levels upon Alexa's request, and another 8 million at a premium instead of future milestone payments.

This has a potential if approved of possibly a 300-400% gain in the next month from these levels IMO.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.